Advance the future of GU Oncology by engaging healthcare professionals in scientific exchange, building relationships, and providing expert insights on non-muscle invasive bladder cancer to enhance patient care and clinical research outcomes.

Champion the education and engagement of oncology specialists in a defined territory, driving awareness and adoption of innovative treatments for FGFR2-positive cholangiocarcinoma through strategic account management and collaboration.

Lead the charge in advancing oncology care by managing key accounts, educating multidisciplinary teams, and driving strategic initiatives to enhance patient outcomes in FGFR2-positive cholangiocarcinoma treatment.

Champion scientific engagement in GU Oncology, focusing on NMIBC. Build relationships with healthcare professionals, provide expert insights, and support clinical research while adhering to compliance and regulatory standards.

Lead and develop a high-performing field Medical Affairs team, translating strategy into actionable objectives. Engage with healthcare professionals and stakeholders to drive scientific exchange and enhance patient outcomes in oncology.